In line with these observations, the presence EpCAM+/CD44+ cancer stem cells in the colorectal cancer patient tissues is significantly correlated with more aggressive and higher tumour grade [93], further highlighting the critical role of EpCAM and the cancer stem cells in promoting tumour progression and survival as well as conferring resistant towards chemotherapeutic agents. This evidence concerns the gene CD44 and cancer.